Interferon-associated left ventricular dysfunction in a liver transplant recipient

Digestive Diseases and Sciences

Volumn 41, Issue 7, 1996, Pages 1500-1503

  Mateo, R ^a   Jethmalani, S ^a   Angus, D C ^a   Gorcsan III, J ^a   Uretsky, B ^a   Fung, J ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

interferon; left ventricle; liver transplant

Indexed keywords

ALPHA INTERFERON; INTERFERON;

ADULT; ARTICLE; CASE REPORT; HEART DISEASE; HEART LEFT VENTRICLE; HUMAN; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL;

ADULT; ELECTROCARDIOGRAPHY; HEPATITIS C; HUMANS; INTERFERON-ALPHA; LIVER TRANSPLANTATION; MALE; RECURRENCE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0030016885     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02088579     Document Type: Article

References (21)

1. Davis G: Interferon treatment of viral hepatitis in immunocompromised patients. Semin Liver Dis 9(4):267, 1989
2. DiBisceglie AM, Marten P, Kassianides C, et al: Recombinant Interferon alpha therapy for chronic hepatitis C: A randomized, double-blind, placebo-controlled trial. N Engl J Med 321:1506, 1989
3. Renault P, Hoofnagle J: Side effects of alpha interferon. Semin Liver Dis 9(4):273, 1989
4. Sonnenblick M, Rosin A: Cardiotoxicity of interferon: A review of 44 cases. Chest 99(3):557, 1991
5. Mateo R, Wang L, Sico E, et al: Alpha-interferon for clinical hepatitis C recurrence following liver transplantation. 1993 (submitted)
6. Erstad B: Severe cardiovascular effects in association with acute, high-dose corticosteroid administration. DICP, Ann Pharmacother 23:1019, 1989
7. Cohen J, Kaplan M: Left-sided heart failure presenting as hepatitis. Gastroenterology 74(3):583, 1978
8. Sisto A, Van Doesburg N, Deal C, et al: Decompensated cardiomyopathy mimicking hepatitis in a 13-year-old girl. J Pediatr Gastroenterol Nutr 9:126, 1989
9. Levine S, Walsh T, Martinez A, et al: Cardiopulmonary toxicity after liposomal amphotericin B infusion. Ann Intern Med 114:664, 1991
10. Singh D, Gupta P, Gupta S, et al: Cardiac changes in acute viral hepatitis in Varanasi (India): Case reports. J Trop Med Hyg 92:243, 1989
11. Myocardial disease. In M Cheitlin, M Sokolow, M Mellroy (eds). Clinical Cardiology. Norwalk, Connecticut, Appleton and Lange, 1993
12. Fung J, Alessiani M, Ahu-Elmagd K, et al: The adverse effects associated with the use of FK 506. Transplant Proc 23(6):3105, 1991
13. Johnson M, So S, Marsh J, Murphy A: QT prolongation and torsades de pointes after administration of FK 506. Transplantation 53(4):929, 1992
14. Kura N, Kojima S, Kakehi R, et al: Dilated cardiomyopathy following alpha-interferon therapy of renal tumor with pulmonary metastases: A case report. Hinyokika Kiyo 38(9):1051, 1992
15. Deyton L, Walker R, Kovacs J, et al: Reversible cardiac dysfunction associated with interferon alpha therapy in AIDS patients with Kaposi's sarcoma. N Engl J Med 321(18):1246, 1989
16. Sonnenblick M, Rosenmann D, Rosin A: Reversible cardiomyopathy induced by interferon. Br Med J 300(5):1174, 1990
17. Cohen M, Huberman M, Nesto R: Recombinant alpha 2 interferon-related cardiomyopathy. Am J Med 85:549, 1988
18. Dusheiko G, DiBisceglie A, Bowyer S, et al: Recombinant leukocyte interferon treatment of chronic hepatitis B. Hepatology 5(4):556, 1985
19. Rudzite V, Skards J, Fuchs D, et al: Serum kynurenine and neopterin concentrations in patients with cardiomyopathy. Immunology. Immunol Lett 32:125, 1992
20. Lampidis T, Brouty-Boyé D: Interferon inhibits cardiac cell function in vitro. Proc Soc Exp Biol Med 166:181, 1981
21. Foss F, Ihde D, Breneman D, et al: Phase II study of pentostatin and intermittent high-dose recombinant interferon alpha 2A in advanced mycosis fungoides/sézary syndrome. J Clin Oncol 10(12):1907, 1992